A detailed history of Park Place Capital Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 259 shares of MEDP stock, worth $86,337. This represents 0.04% of its overall portfolio holdings.

Number of Shares
259
Previous 275 5.82%
Holding current value
$86,337
Previous $111,000 4.5%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$372.0 - $424.34 $5,952 - $6,789
-16 Reduced 5.82%
259 $106,000
Q1 2024

Apr 18, 2024

SELL
$284.87 - $413.31 $6,267 - $9,092
-22 Reduced 7.41%
275 $111,000
Q4 2023

Jan 24, 2024

SELL
$227.52 - $312.68 $1,365 - $1,876
-6 Reduced 1.98%
297 $91,000
Q2 2023

Aug 04, 2023

BUY
$187.26 - $240.17 $3,745 - $4,803
20 Added 7.07%
303 $72,000
Q1 2023

May 02, 2023

SELL
$174.31 - $239.52 $2,266 - $3,113
-13 Reduced 4.39%
283 $53,000
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $45,305 - $67,064
296 New
296 $63,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.